Align Technology, Inc. ALGN
146.78
1.15
0.79%
as of 25 Sep
- Market cap
- $10.4B
- P/E
- 25.5×
Follow ALGN
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Align Technology, Inc. (ALGN) Free cash flow margin
Align Technology, Inc.'s free cash flow margin over the twelve months to 30 June 2026 was 16.3%, up 4.2 percentage points from fiscal 2025 (12.2%). Over the past ten years it has ranged from 7.41% (fiscal 2022) to 24.8% (fiscal 2019); the current reading is higher than 18% of that period. That is above the Medical Instruments & Supplies industry median of 1.61% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Annual
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 12.2% | (3.41) |
| FY2024 | 15.6% | (0.17) |
| FY2023 | 15.7% | 8.33 |
| FY2022 | 7.41% | (12.11) |
| FY2021 | 19.5% | (1.00) |
| FY2020 | 20.5% | (4.31) |
| FY2019 | 24.8% | 7.98 |
| FY2018 | 16.9% | 0.37 |
| FY2017 | 16.5% | 0.08 |
| FY2016 | 16.4% | (5.43) |
Against its own ten years
Low 7.41%
High 24.8%
Ten-year median
16.5%
Current reading's percentile
18
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| ALGN Align Technology, Inc. | 16.3% |
| COO The Cooper Companies, Inc. compare | 16.0% |
| RGEN Repligen Corporation compare | 14.1% |
| ATR AptarGroup, Inc. compare | 8.00% |
| BAX Baxter International Inc. compare | 7.11% |
| AVTR Avantor, Inc. compare | 6.93% |
| BLCO Bausch + Lomb Corporation compare | 2.57% |
| SOLV Solventum Corporation compare | −1.42% |
| STVN Stevanato Group S.p.A. compare | −2.43% |
| Medical Instruments & Supplies industry median | 1.61% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on ALGN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement